The Respiratory Diagnostics Market is projected to reach USD 10.96 billion by 2030 from USD 5.62 billion in 2022, at a CAGR of 8.70% during the forecast period.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Respiratory Diagnostics Market.

  • Based on Product, market is studied across Assays & Reagents, Instruments & Devices, and Software & Services. The Instruments & Devices commanded largest market share of 52.12% in 2022, followed by Assays & Reagents.

  • Based on Test Type, market is studied across Imaging Tests, Mechanical Tests, Molecular Diagnostic Tests, OSA Diagnostic Tests, and Traditional Diagnostic Tests. The Imaging Tests is further studied across Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography, and X-Ray. The Mechanical Tests is further studied across Peak Flow Test, Pulmonary Function Tests, and Spirometry. The Molecular Diagnostic Tests is further studied across DNA Sequencing & Next-Generation Sequencing, In Situ Hybridization, Microarrays, Nucleic Acid Amplification Test, and PCR. The Traditional Diagnostic Tests is further studied across Biochemical Tests, Immunodiagnostics, and Microscopy. The Molecular Diagnostic Tests commanded largest market share of 29.21% in 2022, followed by Imaging Tests.

  • Based on Indication, market is studied across Asthma, Chronic Obstructive Pulmonary Disease, Lung Cancer, Pneumonia, and Tuberculosis. The Chronic Obstructive Pulmonary Disease commanded largest market share of 25.17% in 2022, followed by Tuberculosis.

  • Based on End-User, market is studied across Diagnostic Laboratories, Hospitals & Clinics, and Research Institutes. The Diagnostic Laboratories commanded largest market share of 43.53% in 2022, followed by Hospitals & Clinics.

  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 38.14% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Respiratory Diagnostics Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Respiratory Diagnostics Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Respiratory Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adaltis S.r.l., Altona Diagnostics GmbH, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., bioM?rieux S.A., Bioneer Corporation, CerTest Biotec S.L., Daan Gene Co., Ltd., Diatech Pharmacogenetics srl, Dr?gerwerk AG & Co. KGaA, F. Hoffmann-La Roche Ltd., GE HealthCare Technologies, Inc., Hologic, Inc., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Masimo Corporation, Medtronic PLC, Merck KGaA, ProAxsis by NetScientific PLC, Quest Diagnostics Incorporated, Quidel Corporation, Sansure Biotech Inc., SDI Diagnostics, Inc., Seegene Inc., Siemens Healthineers AG, Somnoware by ResMed Corp., Thermo Fisher Scientific Inc., Vitalograph Ltd., and ZeptoMetrix LLC.

The report offers valuable insights on the following aspects:

  1. Market Penetration: It provides comprehensive information about key players’ market dynamics and offerings.
  2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
  3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
  4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
  5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast for the Respiratory Diagnostics Market?
  2. Which products, segments, applications, and areas hold the highest investment potential in the Respiratory Diagnostics Market?
  3. What is the competitive strategic window for identifying opportunities in the Respiratory Diagnostics Market?
  4. What are the latest technology trends and regulatory frameworks in the Respiratory Diagnostics Market?
  5. What is the market share of the leading vendors in the Respiratory Diagnostics Market?
  6. Which modes and strategic moves are suitable for entering the Respiratory Diagnostics Market?